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Abstract.  We have prepared a  functional fluorescent 
analogue of the glycolytic enzyme aldolase (rhodamine 
[Rh]-aldolase), using the succinimidyl ester of 
carboxytetramethyl-rhodamine. Fluorescence redistri- 
bution after photobleaching measurements of the 
diffusion coefficient of Rh-aldolase in aqueous solu- 
tions gave a  value of 4.7  ×  10  -7 cm2/s, and no immo- 
bile fraction. In the presence of filamentous actin, 
there was a 4.5-fold reduction in diffusion coefficient, 
as well as a  36%  immobile fraction, demonstrating 
binding of Rh-aldolase to actin. However, in the pres- 
ence of a  100-fold molar excess of its substrate, fruc- 
tose  1,6-diphosphate, both the mobile fraction and 
diffusion coefficient of Rh-aldolase returned to control 
levels, indicating competition between substrate bind- 
ing and actin cross-linking. When Rh-aldolase was 
microinjected into Swiss 3T3 cells, a  relatively uni- 
form intracellular distribution of fluorescence was ob- 
served.  However, there were significant spatial differ- 
ences in the in vivo diffusion coefficient and mobile 
fraction of Rh-aldolase measured with fluorescence 
redistribution after photobleaching. In the perinuclear 
region, we measured an apparent cytoplasmic diffusion 
coefficient of 1.1  ×  10  -7 cm2/s  with a  23%  immobile 
fraction; while measurements in the cell periphery 
gave a value of 5.7  ×  10  -g cm2/s, with no immobile 
fraction. Ratio imaging of Rh-aldolase and FITC- 
dextran indicated that FITC-dextran was relatively ex- 
cluded from stress fiber domains. We interpret these 
data as evidence for the partitioning of aldolase be- 
tween a  soluble fraction in the fluid phase and a  frac- 
tion associated with the solid phase of cytoplasm. The 
partitioning of aldolase and other glycolytic enzymes 
between the fluid and solid phases of cytoplasm could 
play a  fundamental role in the control of glycolysis, 
the organization of cytoplasm, and cell motility. The 
concepts and experimental approaches described in 
this study can be applied to other cellular biochemical 
processes. 
TIaOUGH glycolytic metabolism is well-defined at the 
biochemical level, the dynamic and spatial organiza- 
tion of glycolysis in living cells has not been charac- 
terized to date. After the elucidation of mitochondrial struc- 
ture and function 35 years ago (28) it was generally assumed 
that a  corresponding  organelle  for glycolysis must exist. 
Efforts to isolate and to characterize such an organelle were 
unsuccessful, leading de Duve (26) to conclude that the long- 
sought"glycolytic  particle" did not exist. As a result, the cur- 
rent concept of in vivo glycolytic metabolism is based on an 
assumption of dilute solution chemistry, due largely to the 
absence of evidence for a discrete glycolytic organelle. 
There has been evidence for over 20 years that some glyco- 
iytic enzymes bind to structural proteins, particularly actin. 
The interaction of aldolase with actin has been demonstrated 
histochemically (8, 61), biochemically (5,  6,  8, 69),  ultra- 
structurally (16, 52),  and with immunofluorescence tech- 
niques  (27).  In  fact,  aldolase  was  among the  first actin- 
binding proteins to be identified (10), although this interac- 
tion was not considered specific at the time. It has since been 
well-characterized in terms of both its native structure, enzy- 
matic activity, and its actin-binding qualities.  Some of the 
characteristics  of vertebrate  striated  muscle  aldolase  are 
reviewed  in  Table  I.  Aldolases  from  other  mammalian 
sources are reasonably well-conserved (56). 
The potential significance of the localization of glycolytic 
enzymes has been indicated by reconstitution experiments 
under conditions of physiological ionic strength and protein 
concentration (15), and in the presence of the regulatory pro- 
teins of skeletal muscle (75). This work suggested that previ- 
ously reported "glycolytic component" complexes (13, 14, 
34)  were  actually complexes of glycolytic enzymes with 
structural proteins, and implied that the glycolytic particle 
might exist as such a complex. The model for the cytoplas- 
mic organization of glycolytic enzymes that has  emerged 
from Clarke and Masters' work is that there is a "plating" of 
glycolytic enzymes around the filamentous actin (F-actin) ~ 
core of microfilaments (48).  Masters proposed a dynamic 
t.  Abbreviations  used  in  this paper:  Daq, aqueous diffusion coefficient; 
Dcyto, apparent cytoplasmic diffusion coefficient; D/P,  dye/protein ratio; 
F-actin, filamentous actin; FDP, fructose 1,6-diphosphate; FRAP, fluores- 
cence redistribution after photobleaching; Rh, rhodamine. 
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Property  Reference No. 
Molecular 
mass 
Conformation 
Subunits 
Substrate 
Cellular 
concentrations 
160,000  D  39 
heterotetramer  33 
361  residues per 
monomer  33 
2×ct 
(asn at 358)*  39 
2xl3 
(asp at  358)  39 
FDP 
aldolase 88  IxM 
FDP  160  I.tM 
calculated from 65 
calculated from 67 
* Subunits are identical  except for this single-residue difference. 
three-way equilibrium among monomeric actin, F-actin, and 
glycolytic enzymes, resulting in a microdomain of glycolytic 
enzymes surrounding actin filaments. If this model is cor- 
rect,  then glycolytic enzymes could exist as a  solid state 
chemical reaction series and the prevailing view that glyco- 
lytic enzymes are  dissolved in  the aqueous  phase of the 
cytoplasm is only partially correct. Alternatively, enzymes 
associated with the solid phase of  cytoplasm could be a kinet- 
ically modified subset of glycolytic enzymes (50). 
It has also been suggested that glycolytic enzymes have a 
functional duality, playing structural roles, as well as their 
established catalytic roles (18). In such a dual role, glycolytic 
enzymes could be integrators of cytoplasmic structure and 
function, by binding to actin as well as to substrate. This ex- 
citing idea is supported by evidence obtained in vitro that (a) 
the actin-geUing  activity of aldolase is inhibited by its sub- 
strate fructose 1,6-diphosphate  (FDP; 18), (b) the kinetics of 
aldolase activity are modified by the actin-containing fila- 
ments of skeletal muscle (74), and (c) the actin filaments of 
muscle tissue perturbed  by  electrical  stimulation (19) or 
anoxia (20) bind a substantially higher percentage of  aldolase 
than do those of unperturbed muscle. In view of the above 
evidence, we agree with Clarke et al. (21) that aldolase-actin 
interactions cannot be prejudged as "non-specific" (24). 
Investigations of glycolysis by biochemical methods  in 
vitro,  as  well  as  histochemical  and  ultrastructural  ap- 
proaches in fixed cells, have been valuable; however these 
approaches have serious limitations: cells cannot be modeled 
as dilute solutions, temporal variations cannot be detected, 
and spatial information is lost (23, 31, 46, 47, 77). Our ap- 
proach to studying the possible relationship of glycolysis to 
cytoplasmic structure was to develop a fluorescent analogue 
of aldolase (rhodamine [Rh]-aldolase) and to perform ex- 
periments on individual living Swiss 3T3 cells using fluores- 
cent analogue cytochemistry, fluorescence redistribution af- 
ter photobleaching (FRAP), and digital imaging (71, 72). We 
found a  relatively uniform distribution of Rh-aldolase  in 
cells, but significant spatial differences in both its diffusion 
coefficient: and mobile fraction. The evidence we present is 
2. The term diffusion coefficient can only be used rigorously for measure- 
ments made in aqueous solution (Daq). We refer to cytoplasmic mobility as 
an apparent diffusion coefficient (Dcyto) to compare aqueous and cytoplas- 
mic values. 
consistent with the concept that glycolytic enzymes can exist 
in both the fluid phase and solid phase of cytoplasm. 
Materials and Methods 
Materials 
All biochemicals were purchased from Sigma Chemical Co.  (St.  Louis, 
MO) unless otherwise specified. 
Fluorescent Labeling of  Aldolase 
Purified  rabbit  muscle  aldolase  was  reacted  with  carboxytetramethyl- 
rhodamine succinimide ester (Molecular Probes Inc.,  Eugene, OR) by a 
method analogous to that used in the iodination of aldolase with an N-hy- 
droxysuccinimide acylating agent (11, 20). A 3.0 M ammonium sulfate sus- 
pension containing 5 mg of aldolase in 230/al was dialyzed to equilibrium 
against 1,000 vol of 3 mM Tris-HCl and 10 mM EDTA at pH 7.5 (labeling 
buffer).  The dye was dissolved in dimethyl formamide (Eastman Kodak 
Co., Rochester, NY) shortly before use. Immediately before reaction, a  10- 
fold molar excess of dye/dimethyl formamide solution (based on the tetra- 
meric weight of aldolase) was dissolved in a  volume of 200 mM borate 
buffer, pH 8.5, equal to that of the dialyzed aldolase solution. This mixture 
was then added dropwise with continual stirring to the aldolase, and in- 
cubated on ice for 15 min. The reaction was terminated by adding sufficient 
1.0 M  ethanolamine to bring the final concentration to  100 raM, and was 
then stirred on ice for an additional 3 min. The reacted mixture was dialyzed 
in collodion bags (Schleicher and Schuell, Inc., Keene, NH) in the dark on 
ice for 48 h against four changes of labeling buffer to remove free dye. The 
final concentration of Rh-aldolase was 2-4 mg/ml, and it could be stored 
on ice for 1 wk with an enzymatic activity loss of ~<1% per day. For assays 
of activity, parallel batches of aldolase were prepared in which a control was 
treated identically to the Rh-aldolase, except that no dye was present in the 
aliquot of dimethylformamide which was added to the reaction buffer (unla- 
beled controls). 
Protein Assay 
The protein assay used in these experiments was adapted from the Schac- 
terle and Pollack (59) modification of the Lowry et al. (41) assay. All stan- 
dards and samples were read at 750 nm (instead of 650 rim) to minimize 
interference from the fluorochrome absorbance maximum at 557 nm in the 
labeled species. The dye/protein ratio (D/P) of the labeled species was cal- 
culated by standard methods (62), using a molar extinction coefficient for 
the dye of 55,000 M -t cm  -~ (product data from Molecular Probes, Inc.). 
Fluorescence Spectroscopy 
Appropriately diluted samples of free dye or Rh-aldolase in the presence 
or absence of FDP were scanned using the photon counting mode of a spec- 
trofluorometer system (model Fluorolog 2; Spex Industries, Inc., Edison, 
NJ). For excitation spectra, emission at 583 nm was monitored, and the ex- 
citation wavelength for emission spectra was 557 nm, using a slit bandwidth 
of,'~l nm in both cases. Rayleigh scatter peaks, at 583 and 557 for excitation 
and emission spectra, respectively, (3-4 points each), were removed manu- 
ally after the scans. 
Column Chromatography 
A  10-mm x  45-cm Sephacryl S-300 (Pharmacia Fine Chemicals, Piscata- 
way, NJ) column was equilibrated with a buffer consisting of 50 mM KCI, 
1 mM EDTA, and 10 mM Tris-HCl, pH 7.5 (column buffer) at 4°C. Samples 
of aldolase  and  Rh-aldolase  were  dialyzed  against  several  changes of 
column buffer, loaded on the column, and eluted at constant pressure using 
a peristaltic pump; 1.0 ml fractions were collected, and the absorbance of 
fractions was read at 280 nm. 
FITC-Dextran 
FITC-dextran of 156,500 mol wt was size fractionated over a 45-nun x  l+m 
S-300 column equilibrated with column buffer. The fractions constituting 
the central 60 % of the Gaussian elution profile were pooled, dialyzed exten- 
sively  against  distilled  water  at  4°C,  lyophilized,  stored  frozen,  and 
resuspended into the desired buffer before use. Minor leading and trailing 
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fractionated  FITC-dextran had an elution profile  similar to  that of Rh- 
aldolase (K~  =  0.240),  and FRAP measurements of fractionated FITC- 
dextran gave a diffusion coet~cient similar to that of Rh-aldolase (D37,aq = 
4.8  X  10-7),  with significantly less scatter than in the data for D3z,q un- 
fractionated FITC-dextran. 
Gel Electrophoresis 
Rh-aldolase samples were run on 12.5%  SDS-PAGE gels in the presence 
of Ji-mercaptoethanol using the modifications discussed by Standart et al. 
(68) of gel systems described previously (4, 38). Samples of 10-50 ~tg of 
protein were loaded, and the gels were viewed under longwave UV irradia- 
tion before Coomassie Blue staining. 
Enzymatic Activity Assay 
The V.~x and Km of fructose 1,6-diphosphate (FDP) cleavage by aldolase 
were determined using a coupled assay (58, 80). The oxidation of NADH 
when a-glycerophosphate dehydrogenase catalyzes the conversion of di- 
hydroxyacetone phosphate to tt-glyeerophosphate was measured by the de- 
crease in absorbance at 340 nm. The reaction mixture consisted of 50 mM 
Tris-HCl,  1 mM MgClz, 5  mM EDTA, 2.5 mM FDE 0.2 mM NADH, 
and 15 ~.1 (35 U) of a stock solution of a-glycerophosphate dehydrogenase 
and triose phosphate isomerase, at pH 7.5 in a total volume of 1 ml main- 
tained at 25°C by a circulating waterbath. The reaction was initiated by addi- 
tion of 5.0 ~g of aldolase (in 10 I.tl of labeling buffer) to the mixture in a 
cuvette. The decrease in NADH absorbance was monitored with a  chart 
recorder, and slopes of absorbance plots were calculated to determine activi- 
ties of aldolase samples. 
Falling Ball Viscometry 
Falling ball viscometry was used to measure the apparent viscosities of mix- 
tures of aldolase and actin. The conditions used were essentially those of 
Clarke et al. (18), and the procedure was that of MacLean-Fletcher and Pol- 
lard (45, see also 62). Actin prepared by the method of Spudich and Watt 
(64) was used at a final concentration of 1.0 mg/mi throughout, and the assay 
buffer consisted of 40  mM KC1,  1  mM  MgC12,  0.5  mM dithiothreitol 
(DTT), and 10 mM imidazole, at pH 6.8 (imidazole buffer). 300 lal of each 
sample were prepared and drawn into three 100-ktl capillaries (Clay Adams, 
Parsipanny, NJ). The tubes were capped with plasticine, incubated for 30 
min in a waterbath at 37°C, measured in triplicate and the times averaged. 
Straight lines were fit to inverse velocities with a  microcomputer spread- 
sheet using slope and intercept values determined with standard glycerol so- 
lutions (29,  30). We have reproducibly calculated apparent viscosities as 
high as 2,000 centipoise with this method. 
Irradiation of  Samples 
The 514-nm line of an argon ion laser (Spectra Physics, Inc.,  Mountain 
View, CA) was used to perform calibrated irradiation of aldolase and aldo- 
lase-actin mixtures in 100-1al capillary tubes. Tubes were irradiated for 100 s 
at 1 W laser output. The laser beam was expanded from an initial diameter 
of 3 to 13 mm with a microscope objective and a convex lens. The expanded 
beam was then focused with a  34-mm focal length cylindrical lens to il- 
luminate a  rectangular area measuring 2  x  13 mm, yielding a  measured 
power of 300 mW at the target with an irradiance of ~1.2 W/cm  2 (63). 
For assays of actin-binding activity, 1-cm sections of the capillary tubes 
were masked with black vinyl electrical tape, and these windows were held 
at the beam focus by placing the tube in an optical clamp. Samples were 
prepared for failing ball viscometry as above, but drawn into masked tubes. 
The concentration 'of aldolase was 1.5 ~tM (0.24 mg/ml); when actin was 
present it was at a concentration of 1.0 mg/ml. After incubation, a window 
on each tube was irradiated and then inverse velocities were measured in 
the standard way. Apparent viscosity was measured in both irradiated and 
nonirradiated  1-cm sections of each tube. 
For assays of enzymatic activity, a 25 p.l sample of 1.0 I.tM (0.16 mg/mi) 
aldolase was drawn into the center of a capillary tube and both ends were 
plugged with plasticine. The aldolase sample (24 mm in length) was irradi- 
ated with two doses that overlapped by 1 mm. Both irradiated samples and 
nonirradiated controls were drawn into capillary tubes identically. Immedi- 
ately after irradiation, the samples were expelled from the tubes and assayed 
for enzymatic activity (see above). 
FRAP  and Calculations of  Diffusion Coefficients 
FRAP experiments were performed by the Gaussian spot method of Axelrod 
et al.  (9)  essentially as described previously (43, 44).  The 514  tun (for 
rhodamine) and 488 nm (for fluorescein) lines of an ion argon laser (Spectra 
Physics, Inc.) were focused through a Universal microscope equipped with 
epifluorescence optics (Carl Zeiss, Inc., Thornwood, NY). The irradiance 
of the monitoring beam at the specimen plane was ,~3.9 W/cm  2, which was 
an ,'~6,000-fold  attenuation of the bleaching beam. Bleaching times ranged 
from 5 to 50 ms;  15-25%  bleaching gave the most consistent data.  Spot 
radii, measured as described previously (43, 44), were between 6 and 22 
~tm, and fluorescence recovery was monitored for  12-18 s, which repre- 
sented  15-20 half-times of recovery. FRAP curves were analyzed by the 
method of Yguerabide et al. (81) or Van Zoelen et al. (73); the two methods 
agreed well when equally good curve fits were compared. Percent mobile 
fractions, defined as the percent recovery in the experimental timecourse, 
were calculated according to Axelrod et at. (9)  3. Data acquisition and anal- 
ysis was performed using a program written in Asyst (Macmillan Software 
Co.,  New York,  NY) running on an IBM PC-AT equipped with an IBM 
Data Acquisition and Control board. 
In vivo diffusion coefficients were measured with a 63x  Plan-Neofluar 
oil immersion objective (NA =  1.25; Carl Zeiss, Inc.) at 37°C in a modified 
(12)  Sykes-Moore chamber (Bellco  Glass,  Inc.,  Vineland,  NJ)  using a 
temperature-controlled stage (Rainin Instrument Co., Inc., Woburn, MA). 
Neutral  density  filters  were  used  to  attenuate  both  the  monitoring and 
bleaching beams for in vivo FRAP. For in vitro measurements, a 6.3 x  Plan 
Achromat objective (NA =  0.16; Carl Zeiss, Inc.) focused the beam on sam- 
ples drawn into 100 ~tm flat capillaries (Vitro Dynamics, Inc., Rockaway, 
N J) sealed in Flo-Texx (Lerner Laboratories, New Haven, CT). The capil- 
laries were placed on black-anodized machined aluminum flats, on a brass 
constant-temperature stage connected to a circulating waterbath and moni- 
tored with a  small thermocouple (Cole-Parmer Instrument Co., Chicago, 
IL). Mixtures of 1.0 mg/ml F-actin and 1.0 lxM Rh-aldolase were prepared 
in imidazole buffer similarly to those used for falling ball viscometry; FITC- 
dextran-actin mixtures were prepared similarly with the substitution of 2 
~M FITC-dextran in the place of aldolase. 
Temperature conversions for in vitro FRAP data were calculated using 
the Stokes-Einstein equation and published values for the viscosity of water 
(78)  using a  microcomputer spreadsheet program. 
Cell Culture and Preparation 
Swiss 3T3 fibroblasts (ATCC-CCL92; American Type Culture Collection, 
Rockville, MD) were cultured and prepared as described previously (25). 
Microinjection and Imaging 
Approximately 5-10% of a cell volume (72) of a stock solution containing 
2 mg/ml Rh-aldolase and 2 mg/ml FITC-dextran was microinjected into 3T3 
cells (3).  Injected cells were allowed to recover for 30 min to 24 h, then 
placed in a chamber on a temperature-controlled stage and imaged with the 
system described by Bright et al. (12).  Briefly,  a 63×  Plan-Neofluar oil im- 
mersion objective (1.25 NA) with narrow bandpass rhodamine and fluores- 
cein epifluorescence flter sets on a Universal microscope (Carl Zeiss, Inc.) 
was used to image the fluorescence signal on a camera (model ISIT; Dage- 
MTI, Inc., Wabash, MI). Images of 128 averaged video frames were back- 
ground subtracted and processed on an image processor (model VDP 1800; 
VICOM Systems, Inc., Junction City, CA), and photographed with HP-5 
film (Ilford Limited, Cheshire, England) from the high resolution display 
monitor. Rhodamine and fluorescein excitation image pairs (for Rh-aldolase 
and FITC-dextran, respectively) were processed similarly. 
Results 
Characterization of  Aldolase Labeling 
SDS-PAGE of Rh-aldolase samples revealed a  single band 
with a Mr of approximately 41,000  (data not shown).  Nei- 
ther the ct and 15 subunits of aldolase nor labeled and unla- 
beled molecules were distinguishable on these one-dimen- 
3. mobile fraction =  (F~  -  F~)I(Fo  -  F~)  *  100;  immobile fraction =  [1 
-  (F=  -  F~)/(Fo  -  F~)]  *  I00. 
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Figure 1. Excitation and emission spectra of Rh-aldolase. Spectra 
for Rh-aldolase (dashed line) and Rh-aldolase in the presence of a 
100-fold molar excess of FDP (solid line). 
sional gels.  Extensive dialysis in colloidon bags proved as 
effective as  G-100 exclusion chromatography at  removing 
free carboxytetramethyl-rhodamine succinimide ester, and 
gave a better yield, although this is not the general rule with 
other fluorescent probes (62). After dialysis, very little free 
dye was visible at or ahead of the dye front of the gel under 
UV  illumination,  and the single 41,000-Mr  band  was  both 
fluorescent, and Coomassie Blue stained. 
The spectrophotometrically determined molar D/P of the 
Rh-aldolase tetramer was "~2.6:1.0. In the course of varying 
the molar excess of dye during labeling, we found that a dis- 
tinct Poisson distribution of D/P existed. Different batches 
of Rh-aldolase were labeled with D/P of 1.2:1.0, 2.6:1.0, or 
4.1:1.0 depending on the excess of dye available and the time 
of labeling.  Batches labeled at  1.2:1.0  and 2.6:1.0  showed 
very similar activity; both lost ~10-15%  of the enzymatic 
activity exhibited by the unlabeled molecule. Batches labeled 
at 4.1:1.0 showed a significant decrease (=50 %) in enzymatic 
activity. We chose the 2.6:1.0  D/P since that was the highest 
ratio attainable without substantial loss of activity. 
The Rh-aldolase had absorption and emission maxima at 
557 and 583 nm, respectively, yielding a Stokes shift of 26 
0.2 
0.0  ~  .... 
0  I0  20  50 
Fraction Number 
Figure 2.  Elution profiles of aldolase and Rh-aldolase. Samples of 
aldolase (o) and Rh-aldolase (e) were eluted sequentially from the 
same S-300 column (see Materials and Methods); aldolase followed 
Rh-aldolase by •10%;  see text for discussion. 
nm (Fig. 1). Spectra taken in the presence of  a 100-fold molar 
excess of FDP were nearly identical, showing no significant 
absorbance changes or spectral shifts upon substrate bind- 
ing.  These spectra very closely resemble that of the free 
dye when  normalized for fluorescence intensity (data  not 
shown). 
Rh-Aldolase Is Biologically Active 
Rh-aldolase  eluted  from an  S-300  column  with  a  profile 
similar to native aldolase (Fig. 2), demonstrating that the la- 
beled molecule retained tetrameric conformation (49). The 
lead of the labeled species (Kay =  0.238 vs. Kav =  0.268) is 
probably due to a slight change in charge due to the fluoro- 
phore. 
Rh-aldolase (D/P ~2.6:1.0) retained 85-90% of the enzy- 
matic activity (Vmax) of the native molecule. The Km of Rh- 
aldolase was similar to that of the native molecule; both were 
1.5-2.0 txM. These values are slightly higher than the pub- 
lished Km value of 1.0 ~tM for aldolase (74), but internally 
consistent.  Rh-aldolase had enzymatic activity only  1-2% 
lower than that of  the unlabeled control (see Fig. 5, Control), 
demonstrating  that  the  labeling  conditions  (pH  shift, 
dimethyl  formamide,  ethanolamine)  and  not  fluorophore 
binding directly, were primarily responsible for the 10-15 % 
loss of activity in both groups. 
We used falling ball viscometry to assay for actin-gelling 
activity of Rh-aldolase. Rh-aldolase was capable of produc- 
ing actin gels of equal viscosity to those of the unlabeled con- 
trol at slightly higher concentrations. Under our conditions, 
1.25  ~tM  aldolase reproducibly gelled  1.0 mg/ml actin to 
>11,500 centipoise, while 1.5 IxM Rh-aldolase was required 
to reach that viscosity. Over the range of concentrations we 
studied,  Rh-aldolase  had an  average of 81%  of the actin- 
gelling activity of the unlabeled control (Fig. 3). This differ- 
ence suggests that fluorophore binding affects actin-gelling 
activity slightly, and is consistent with our finding that the 
actin-gelling activity was more sensitive to higher D/P than 
the enzymatic activity. FDP inhibited gelation of R-aldolase- 
actin when added at time of mixing, and induced solation 
when added to gels. 
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Figure 3.  Low shear viscometry of Rh-aldolase-actin  and aldo- 
lase-actin mixtures. The viscosity of 1.0 mg/ml F-actin in the pres- 
ence of varying concentrations of unlabeled control aldolase (e), 
Rh-aldolase (e). Inhibition of actin gelation by 100 laM FDP is 
shown by controls for aldolase (o) and Rh-aldolase (rq). 
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Figure 4.  Specificity of actin-gelling activity of Rh-aldolase.  The 
apparent viscosity of mixtures containing  1.0 mg/ml F-actin and l 
I.tM aldolase (except No. 1) is plotted;  100 M of substrate was used 
in each case. 
We also used falling ball viscometry to investigate the de- 
gree of specificity of the  aldolase-actin  interaction.  Mea- 
surements were made in the absence and presence of aldo- 
lase, and in the presence of 100 IxM of each of the following 
sugars: FDP, fructose 6-phosphate, galactose, glucose, and 
D-ribose-5-phosphate (Fig. 4). While FDP reduced the vis- 
cosity of Rh-aldolase and actin gels 98.1%  from the original 
level,  fructose 6-phosphate gave only  a  30.9%  reduction. 
Clearly,  there  is  a  substantial  degree of specificity  in  the 
substrate  inhibition  of  aldolase-actin  binding.  Fructose 
6-phosphate lowered the viscosity slightly more than either 
galactose or glucose,  which had little effect, but allowed a 
viscosity  of aldolase  and  actin  31-fold  greater  than  FDP. 
D-ribose-5-phosphate inhibited gelation quite well,  as pre- 
dicted by its structural  similarity to FDP. 
FRAP  Irradiation Does Not Destroy 
Rh-Aldolase Acavity 
Since Rh-aldolase is a fluorescent analogue of an enzyme it 
was important to know the degree to which the irradiation 
necessary in FRAP measurements reduced its activity. We 
used calibrated irradiation of samples of Rh-aldolase and Rh- 
aldolase-actin mixtures to determine the effect of irradiation 
on both enzymatic and actin-gelling activities. The irradia- 
tion dose (irradiance x  time) received by all samples in these 
experiments was  1.2  Ws/cm  2,  calculated to be equal to an 
average bleaching dose received by the specimens in both the 
in vivo and in vitro FRAP experiments. The increased beam 
intensity due to the use of a higher magnification objective 
in the in vivo experiments was offset by placing neu.tral den- 
sity filters into the beam. 
Both enzymatic and actin-gelling activities of Rh-aldolase 
were reduced by the irradiation dose in these experiments: 
56%  of enzymatic activity  (Fig.  5),  and  >50%  of actin- 
gelling activity (Fig.  6) remained after irradiation.  It is in-, 
teresting to note that while actin-gelling activity was more 
sensitive to overlabeling, enzymatic activity was more sensi- 
tive to irradiation. Additionally, although no change was evi- 
dent in the actin-gelling activity of the unlabeled control after 
irradiation, its enzymatic activity decreased almost as much 
as that of the labeled molecule upon irradiation.  This is not 
unreasonable considering the substantial absorbance of the 
unlabeled control  solution at the irradiation  wavelength of 
514  nm (0.006 vs. 0.033  for Rh-aldolase solution). 
Rh-Aldolase Binds to Actin In Vitro 
The actin-gelling activity demonstrated above is consistent 
with  at  least bivalent binding  of aldolase to actin.  If Rh- 
aldolase does indeed bind to actin, then we would expect a 
reduced diffusion coefficient, an immobile fraction, or both, 
when we measured the mobility of aldolase in the presence 
of actin. We confirmed this prediction by performing in vitro 
FRAP measurements of Rh-aldolase under conditions simi- 
lar to those used for falling ball viscometry (Table II). 
Rh-aldolase had an average mobility of D37,aq  =  4.72 × 
10  -7 cmVs, with no imhaobile fraction, and the presence of 
a  lO0-fold molar excess of FDP did not significantly affect 
these  values.  However,  when  we  measured  its  diffusion 
coefficient in the presence of 1 mg/ml F-actin, we saw two 
distinct changes: D37,aq decreased to 1.04  ×  10  -7 cmVs, and 
there was a  36.3%  immobile fraction.  The observation of 
both an immobile fraction and a reduced D~q suggests that 
several  time  constants  of  recovery  are  involved  for  Rh- 
aldolase-F-actin, and is consistent with multivalent binding 
of aldolase to actin. Successive FRAP measurements in the 
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Figure 5. Effect of irradiation on enzymatic activity of aldolase and 
Rh-aldolase.  1.0 ~tM control aldolase (open bars) and Rh-aldolase 
(hatched bars) were irradiated with 120 Ws/cm  2 at 514 nm;  100% 
is defined as the activity of unlabeled control  aldolase. 
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Figure 6. Effect of irradiation on actin-geiling activity of unlabeled 
control aldolase and Rh-aldolase. The low-shear viscosity of mix- 
tures  containing  1.5  ttM  aldolase  (open bars) or  Rh-aldolase 
(hatched bars) and 1.0 mg/ml F-actin was measured before and after 
irradiation as for Fig. 5. No difference was detected in the activities 
of irradiated and unirradiated  control aldolase. 
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Sample  n*  D20.~q  x  107~  t  D37,aq  x  107  Percent mobile 
Rh-aldolase (1  lxM) 
Rh-aidolase  +  FDP (100  IxM) 
Rh-aldolase  +  F-Actin (1  mg/ml) 
Rh-aidolase  +  FDP  +  F-Actin 
FD150  (1  IxM) 
FD150  +  Aldolase  +  F-Actin 
26  3.08  +  1.16§  4.72  +  1.78  101.7  +  6.9 
12  3.12  +  1.23  4.78  +  1.88  96.1  +  9.6 
20  0.68  +  0.08  1.04  +  0.12  63,7  +  10.4 
26  2.72  +  1.02  4.18  +  1.57  98.6  +  5.1 
10  3.15  +  0.37  4.84  +  0.57  106.2  +  5.4 
14  2.84  +  0.19  4.35  +  0.29  102.8  +  4.9 
* Number of measurements  used in calculating  the mean. 
Aqueous diffusion coefficients (cm2/s) were measured at 22-24°C and normalized  to 20 (D20.,q) and 37°C (D37.aq) for comparison to in vivo data;  see Materials 
and Methods for method. 
§ Mean  +  SD. 
same spot (repeat FRAP) gave progressively greater recov- 
ery percentages (data not shown). The 4.5-fold decrease in 
diffusion coefficient, and the appearance of a significant im- 
mobile fraction were largely reversed when  100 ~tM FDP 
was  included in the aldolase-actin mixture. 
FD150 had no immobile fraction, and only a slight reduc- 
tion of diffusion coefficient in the aldolase-F-actin gel. Even 
in the absence of actin-binding activity of FDI50, diffusion 
barrier  theory  (53)  predicts  a  6-10%  lower  diffusion 
coefficient-in the F-actin-aldolase gel,  due to the obstruc- 
tions of the gel network. Our data are consistent with this 
prediction. 
The Cellular Distribution of  Aldolase Is 
Relatively Uniform 
Imaging cells coinjected with Rh-aldolase and FITC-dextran 
revealed that aldolase was distributed in a pattern similar to 
that of a dextran of a comparable size (Fig. 7). Both mole- 
cules were excluded from the nucleus and from vesicles, but 
distributed into the cell periphery equally well. Images of in- 
jected cells were remarkably uniform from 30 min to 24 h 
postinjection,  demonstrating  that  Rh-aldolase  integrated 
rapidly into a  stable cellular pool of aldolase, and did not 
significantly affect cell viability. A notable exception to equal 
distribution of Rh-aldolase and FITC-dextran fluorescence 
Figure 7. Fluorescence images of a cell coinjected with Rh-aldolase and FITC-dextran.  Images of a  3T3 cell coinjected with Rh-aldolase 
(a) and FITC-dextran (b) are compared; typical perinuclear (solid arrow) and peripheral (open arrow) FRAP sites are shown. Large arrow- 
head in a  indicates centrosome, small arrowheads  in b  mark  stress fiber exclusion of dextran.  Bar,  10  gm. 
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note clear stress fiber exclusion in b. Bar, 10 ltm. 
was evident  in  the periphery of cells with well developed 
stress fibers. In the Rh-aldolase images, stress fibers could 
be detected by a slight negative staining effect (Figs. 7 a and 
8 a; see reference 2). However, in the FITC-dextran images, 
much more dramatic exclusion of FITC-dextran from zones 
around stress fibers was evident at the same plane of focus 
(Figs.  7  b  and 8 b). 
To normalize the  aldolase image in Fig.  8  for effects of 
pathlength and accessible volume on fluorescence intensity, 
we generated a  ratio image in  which  Rh-aldolase fluores- 
cence  was  divided  by  FITC-dextran  fluorescence;  bright 
areas in this image have a high concentration of aldolase rela- 
tive to dextran (12, 70, 77). A relatively increased concentra- 
tion of Rh-aldolase in zones around stress fibers is visualized 
as the bright, thin lines in Fig. 9. FITC-dextran is relatively 
excluded  from these areas.  Bright regions around cell pe- 
riphery are probably due to movement of the cell between 
successive images. The relatively small differences in distri- 
bution we detected between Rh-aldolase and FITC-dextran 
are significant due to their location, and due to the spatial 
differences in aldolase mobility (see below). 
Spatial Differences in Aldolase Mobility Exist In Vivo 
We used FRAP measurements to determine the mobility of 
Rh-aldolase and FITC-dextran in living cells. It quickly be- 
came apparent that there were significant spatial differences 
in aldolase mobility within individual cells.  Consequently, 
we performed FRAP measurements in two locations: peri- 
nuclear and peripheral regions as shown in Fig 7 a. Periph- 
eral FRAP sites were areas with well-developed stress fibers 
(20-40% of beam area) visible by phase contrast. The data 
from these experiments are presented in Table III. 
In the perinuclear region,  aldolase had a  Dcyto of 1.1  x 
10  -7 cm2/s, a  value 4.5-fold lower than its aqueous diffusion 
coefficient. This reduction may be explained simply by the 
higher  viscosity  of the  aqueous  phase  of the  cytoplasm, 
which has been reported to be between 3 and 6  centipoise 
(40,  42,  51, 55).  However, the immobile fraction of 23 % is 
not  explained by cytoplasmic viscosity,  and  may reflect a 
bound fraction of aldolase in the perinuclear region. No im- 
mobile fraction was evident in  the  cell periphery,  but  the 
diffusion coefficient was 6.28  ×  10  -8 cm2/s, about twofold 
lower than that of the perinuclear region. 
Repeat FRAP in several perinuclear sites showed that a ma- 
jority of the immobile fraction of Rh-aldolase was bleached 
by the initial measurement. The diffusion coefficient of the 
mobile fraction of Rh-aldolase in the second measurement 
was only slightly lower than in the original measurement at 
those spots. Since the repeat FRAP measurements followed 
the initial measurements by several minutes, these data estab- 
lish that if the apparent immobile fraction we observed was, 
in fact, a very low mobility fraction, then its mobility must 
be at least several orders of magnitude lower than that of the 
higher mobility fraction (37). 
We found no immobile fraction of FITC-dextran in either 
perinuclear or peripheral regions. The diffusion coefficients 
of FITC-dextran were intermediate between the two aldolase 
values and in good agreement with published in vivo values 
for similarly sized dextrans (44).  The lack of difference in 
the perinuclear  and peripheral mobilities of FITC-dextran 
rules  out  significant effects of cell  geometry on measured 
values of D~y~o. 
Discussion 
We have identified an immobile fraction of Rh-aldolase in the 
perinuclear region of living 3T3 cells, and we also found spa- 
tial  variation  in  its  D~yto. Coinjected  FITC-dextran shows 
neither an immobile fraction nor spatial variations in mobil- 
ity. These experiments are direct evidence that a fraction of 
aldolase partitions into the solid phase of living cytoplasm. 
Previous  studies  demonstrated,  using  immunofluores- 
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image of Fig. 8 a  divided by the FITC- 
dextran image of Fig. 8 b; arrows indi- 
cate high-ratio area around stress fibers. 
See text for discussion. 
cence, that pyruvate kinase (22) and glyceraldehyde-3-phos- 
phate dehydrogenase (21) have distributions very similar to 
actin in stress fibers, although this has not yet been demon- 
strated with aldolase. The uniform distribution of Rh-aldo- 
lase we observed in vivo initally seemed paradoxical, in light 
of  data demonstrating that aldolase hinds to F-actin (7, 15, 16), 
skeletal muscle homogenates (19), and fetal brain homoge- 
hates  (17) with affinities greater than or equal to those of 
other glycolytic enzymes. However, the spatial differences 
we measured in the mobile fraction and diffusion coefficient 
of Rh-aldolase  indicate  that  a  sensitive  equilibrium  may 
regulate the actin-binding activity of aldolase in vivo. There- 
fore, localization of proteins such as aldolase to actin fibers 
based on immunofluorescence data could lead to a false im- 
pression about the true dynamics of the interactions. 
Table IIl. In Vivo FRAP Data 
rt*  D37,cyto  ×  10s~  t  Percent  mobile 
Rhodamine-aldolase 
Perinuclear  15  11.0  +  3.31§  76.9  ±  6.7 
Peripheral  19  5.73  ±  2.16  107.2  ±  5.6 
Repeat perinuclear  5  9.40  ±  3.80  96.6  5:3.7 
FITC-dextran 
Perinuclear  12  6.86  ±  2.20  102.5  ±  8.5 
Peripheral  13  6.28  ±  1.96  100.8  ±  8.6 
* Number of measurements used in calculating the mean. 
* Cytoplasmic diffusion coefficients  (cm2/s) were measured at 37°C. 
§ Mean 5: SD. 
Evidence  for a Microdomain of  Aldolase Around 
Stress Fibers 
We have considered two models to explain our in vivo data: 
hindered cytoplasmic diffusion and  dynamic equilibrium. 
First,  increasingly hindered diffusion, or higher microvis- 
cosity, in peripheral cytoplasm could account for the twofold 
lower peripheral D~to of Rh-aldolase (Table III).  However, 
at least two lines of evidence argue against this model: (a) 
it does not by itself account for the perinuclear immobile 
fraction, and (b) the relative lack of spatial difference in the 
diffusion coefficient of our FITC-dextran control is inconsis- 
tent with this model. 
The second model, which we favor, is based on an on/off 
rate for the aldolase-actin interaction in the cell periphery 
which is  faster than we have resolved.  This could be ex- 
plained by a dynamic equilibrium between aldolase, actin, 
and FDP. Such an equilibrium could create a microdomain 
not only of aldolase, but of glycolytic activity around actin 
filaments and would be compatible with the dynamic equilib- 
rium model proposed by Masters (48). The second model is 
also consistent with the fact that aldolase binds to the deter- 
gent resistant cytoskeleton in a variety of systems (32, 35, 36, 
60). Our evidence for spatial differences in aldolase mobility 
suggests that local differences in cell metabolism could sig- 
nificantly affect the degree to which aldolase binds to actin. 
For example, glyco'lytic metabolism might be more impor- 
tant in  the mitochondrion-poor cell periphery than  in the 
perinuclear region. Energetically, the cell may not be able 
to afford an immobile fraction of aldolase in the periphery 
The Journal of Cell Biology, Volume 107, 1988  988 if it is actively turning over substrate, and is thus inhibited 
from binding to actin.  Presumably, there would be corre- 
sponding  spatial  heterogeneity  in  FDP  concentrations, 
though this has not been demonstrated. 
Even though the interactions between glycolytic enzymes, 
their substrates, and actin may be relatively weak, they must 
nonetheless be extremely important due to the very high lo- 
cal concentrations of these molecules around isotropically 
organized actin filaments and/or stress fibers. If indeed dy- 
namic microdomains of glycolytic activity exist, we would 
expect these areas to relatively exclude inert molecules. Our 
data  showing  selective  exclusion  of  FITC-dextran  from 
regions around stress fibers are consistent with this predic- 
tion, as well as with a model in which glycolytic enzymes 
would  exist in  arrays  around  the  actin  cytoskeleton. The 
slight exclusion of Rh-aldolase from stress fibers (Fig. 8 a) 
suggests that it binds primarily to the surface, and does not 
integrate into the interior of fibers. Some glycolytic enzymes 
may not be directly associated with actin, but instead may 
be bound indirectly, in a "piggy-back" fashion on other glyco- 
lytic enzymes (22). It is important to point out that a solid 
state model such as this does not imply that a series of en- 
zymes would be truly immobilized, or static.  Rather, they 
would be confined to a microdomain in which the time-aver- 
aged probability of specific arrays and sequences occurring 
would be far higher than if the enzymes were freely soluble. 
A truly immobilized enzyme fraction, such as the perinu- 
clear aldolase fraction we have described, might represent 
a kinetically distinct subset. The phenomenon of ambiguity 
has been suggested for the association of hexokinase with the 
mitochondrial  membrane  (79).  Other glycolytic enzymes 
may also be ambiguous;  for example, binding of enzymes 
to actin may act essentially as an allosteric effector in vivo 
(50), since it has been demonstrated in vitro that actin-bind- 
ing can modify both the  Km  and Vmax of aldolase by two 
orders of magnitude under appropriate conditions (74). An- 
other result of the binding of glycolytic enzymes to actin 
would be competition between glycolytic enzymes and other 
actin-binding proteins (e.g., myosin) for binding sites on ac- 
tin. A complex and sensitive regulatory system coupling cy- 
toplasmic structure, motility, and glycolysis could result. 
Evidence That the Perinuclear Immobile Fraction of 
Aldolase Represents a Specific Interaction 
One possible important objection to direct comparison of cy- 
toplasmic diffusion coefficients of molecules conjugated to 
different fluorochromes concerns differing interactions  of 
various fluorochromes with intracellular components. As a 
control for this, all fluorochromes to be used must be bound 
to similar tracer particles,  and their cytoplasmic diffusion 
coefficients measured. Changes in the mobile fraction are of 
particular concern, as they may represent selective partition- 
ing of tracers labeled with hydrophobic fluorochromes into 
membrane compartments. This concern has been addressed 
for  a  range  of particle  sizes  using  both  rhodamine-  and 
fluorescein-labeled dextrans  with  the  finding that  no  sig- 
nificant fluorochome based differences in  Dcyto exist (43). 
This finding indicates that the mobilities of rhodamine- and 
fluorescein-labeled analogs may be accurately compared in 
vivo. 
A  second  important concern is  possible  photooxidative 
cross-linking or breakage of filaments (or other cell compo- 
nents) caused by the irradiation used in FRAP and extended 
imaging experiments. There is recent evidence that bleach- 
ing irradiation doses used in FRAP experiments can create 
artifacts in populations of both labeled and unlabeled actin 
in vitro (63). Consequently, measurements of the effects of 
irradiation on analogue activity should be considered an es- 
sential part of experiments with biologically active fluores- 
cent analogues. Our in vitro FRAP evidence that Rh-aldolase 
diffuses at the predicted rate in the presence of F-actin and 
excess FDP (Table II) demonstrates that the bleaching irradi- 
ation used neither cross-links nor disrupts  actin filaments 
significantly. Additionally, the fraction of Rh-aldolase which 
absorbs a bleaching dose of irradiation in FRAP experiments 
(2-4%) retains much of its actin-binding and enzymatic ac- 
tivities. Since Rh-aldolase constitutes a small percentage of 
the cellular pool of aldolase (see below), the activity lost is 
unlikely to affect metabolism significantly. 
How Much Aldolase Is in Cells? 
As an initial estimate for cellular concentrations of aldolase, 
actin, and FDP, we have used the extensive literature on stri- 
ated  muscle  glycolytic enzymes and  intermediates,  com- 
bined  with  data  on  nonmuscle  cell  volumes  and  protein 
concentrations. We will consider intracellular actin concen- 
tration as a reference point, since it has been shown to make 
up '~10%  (wt/wt) of total protein of nonmuscle cells (57). 
Assuming an average mammalian cellular protein content of 
~0.75 ng (76), and an average volume of ~4  x  10  -12 liter 
(1), there  would  be  ,~109 actin  molecules/cell (72).  This 
results in a cellular actin concentration of "d9 mg/ml, con- 
sistent with a total cellular protein concentration of '~ 200 
mg/ml (66, 67). If we assume that approximately half the to- 
tal cellular volume is cytoplasmic, due to the volume fraction 
of mitochondria, vesicles, and endoplasmic reticulum, then 
the net actin concentration would be ,,040 mg/ml, or 900 tiM. 
Srere (65) reported muscle tissue aldolase concentrations 
of 4.5  x  l0  -s mol/kg, which equals '~7 mg/ml when aver- 
aged over total tissue weight. If we again assume that approx- 
imately half of the total cellular volume is cytoplasmic  4, the 
next aldolase concentration would be "-,14 mg/ml, or 88 p.M. 
This is ~108 molecules/cell, or 10-fold fewer aldolase tetra- 
mers than actin monomers. Since actin is not uniformly dis- 
tributed in cells, however, the local actin/adolase ratio may 
vary considerably. 
For in  vivo FRAP  experiments,  we  injected cells  with 
~10  -~3 I (~10%  of a cell volume) of a solution containing 
2-4 mg/ml aldolase. Based on the calculations above, this 
would be an injection of analog equaling 2-4% of the total 
cellular pool of aldolase. This fraction is small enough that 
it is likely to rapidly incorporate into the cellular pool, and 
unlikely to affect normal metabolism significantly. A fraction 
much smaller than this would result in a weaker fluorescence 
signal with corresponding difficulties in detection. 
The disparity  between our detailed biochemical under- 
standing of glycolysis and our lack of knowledge about the 
spatial organization of glycolysis in cytoplasm has been a 
dilemma for modern biology. Since glycolytic enzymes are 
such abundant cytoplasmic proteins, understanding the orga- 
4. Nuclei in a variety of tissues have been shown to contain all the glycolytic 
enzymes (54); consequently, nuclear volume cannot be subtracted from total 
cell volume for the purpose of computing net cytoplasmic volume. 
Pagliaro and Taylor Aldolase in the Solid Phase of Cytoplasm  989 nization of glycolysis in living cells will  significantly en- 
hance our knowledge not only of glycolysis, but of the nature 
of cytoplasm. The approach we describe will be useful with 
other enzymes and could be a significant tool in characteriz- 
ing metabolism in vivo. 
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